Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Value investing can be a powerful strategy for new investors. Learn key tips to enhance your investment skills and achieve better returns.
28,096 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Oracle stock popped today as investors cheered a strong earnings beat and accelerating cloud growth. This article bre...
A new wave of small modular reactors could reshape the US power mix. This article explains why NuScale Power is catch...
In 2025, Tim Cook and Reed Hastings stepped back from the helm with quiet discipline, delivering a leadership playboo...
As CI&T launches into 2026, investors are scanning for momentum, margin resilience, and strategic bets. This deep div...
Star Bulk reported a solid Q1 2026, reflecting steady demand for commodities and a modern fleet. This article unpacks...
A risk disclosure in SpaceX’s pre-IPO paperwork flags space-based warfare threats to Starlink. As investors watch an ...
Investors are eyeing yuanbao (yb) 2026 earnings as the company pivots toward new revenue streams. This guide breaks d...
Applied Optoelectronics falls 12% as AI optics trade cools, with peers Lumentum and Coherent also lower. Analysts cit...
A cheaper Brazil-focused ETF is outperforming its larger peer in 2026, prompting a rethink of how investors access Br...
Newmont released after-hours results, signaling steady production yet revenue depends on gold prices. The company gui...
Investors grapple with AI-driven disruption as markets remain volatile in early 2026. Experts outline disciplined ste...